Researchers comparing Thymosin Alpha-1 and LL-37 are usually mapping which compound fits a given immune-signaling research question. This is descriptive reference information about how they differ, not guidance or a recommendation. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.
| Thymosin Alpha-1 | LL-37 | |
|---|---|---|
| Type | 28-amino-acid thymic peptide (prothymosin alpha) | 37-residue human cathelicidin fragment |
| Primary research area | T-cell and dendritic-cell signaling | Antimicrobial activity, innate immunity |
| Handling | Lyophilized; store frozen | Lyophilized; store frozen, avoid freeze–thaw |
Thymosin Alpha-1 is a thymic peptide studied in adaptive-immune research, particularly T-cell differentiation and Toll-like-receptor signaling.
Thymosin Alpha-1 product page and batch COA · Thymosin Alpha-1 reconstitution guide
LL-37 is a cathelicidin antimicrobial peptide studied in innate-immune and direct antimicrobial research.
LL-37 product page and batch COA · LL-37 reconstitution guide
Thymosin Alpha-1 is associated more with adaptive-immune signaling research, LL-37 with innate-immune and antimicrobial research. Researchers pick based on which arm of the immune response their model targets.
Thymosin Alpha-1 is a thymic peptide studied in adaptive (T-cell) immune research; LL-37 is an antimicrobial cathelicidin peptide studied in innate immunity.
Both are immune-research peptides but from different origins and studied in different immune pathways.
No. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.